Literature DB >> 18480315

Irradiation prolongs survival of Alport mice.

Kan Katayama1, Mitsuo Kawano, Ichiro Naito, Hitoshi Ishikawa, Yoshikazu Sado, Nagisa Asakawa, Tomohiro Murata, Kazuki Oosugi, Michiyo Kiyohara, Eiji Ishikawa, Masaaki Ito, Shinsuke Nomura.   

Abstract

Alport syndrome is a hereditary nephropathy that results in irreversible, progressive renal failure. Recent reports suggested that bone marrow transplantation (BMT) has a beneficial, short-term effect on renal injury in Alport (Col4a3(-/-)) mice, but its long-term effects, especially with regard to survival, are unknown. In this study, Alport mice received a transplant of either wild-type or Col4a3(-/-) bone marrow cells. Surprising, laboratory evaluations and renal histology demonstrated similar findings in both transplanted groups. Transplanted cells accounted for >10% of glomerular cells at 8 wk, but type IV collagen alpha3 chains were not detected in glomerular basement membranes of either group by immunofluorescence or Western blot analysis, although Col4a3 mRNA in the kidney could be amplified by reverse transcription-PCR in knockout mice that received a transplant of wild-type bone marrow. Both transplanted groups, however, survived approximately 1.5 times longer than untreated knockout mice (log rank P < 0.05). These data suggested that irradiation, which preceded BMT, may have conferred a survival benefit; therefore, the survival time of knockout mice was assessed after sublethal irradiation (3, 6, and 7 Gy) without subsequent BMT. A strong positive correlation between irradiation dosage and survival time was identified (P < 0.0001). In conclusion, the improved survival observed in Alport mice that received a transplant of wild-type bone marrow might be primarily attributed to as-yet-unidentified effects of irradiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480315      PMCID: PMC2518432          DOI: 10.1681/ASN.2007070829

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  25 in total

1.  Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR.

Authors:  L Overbergh; D Valckx; M Waer; C Mathieu
Journal:  Cytokine       Date:  1999-04       Impact factor: 3.861

2.  Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome.

Authors:  P Heikkila; T Parpala; O Lukkarinen; M Weber; K Tryggvason
Journal:  Gene Ther       Date:  1996-01       Impact factor: 5.250

3.  Genetically modified bone marrow continuously supplies anti-inflammatory cells and suppresses renal injury in mouse Goodpasture syndrome.

Authors:  T Yokoo; T Ohashi; Y Utsunomiya; J S Shen; Y Hisada; Y Eto; T Kawamura; T Hosoya
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

4.  Cyclosporin therapy in patients with Alport syndrome.

Authors:  Marina Charbit; Marie-Claire Gubler; Michèle Dechaux; Marie-France Gagnadoux; Jean-Pierre Grünfeld; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

5.  Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker.

Authors:  A Molteni; J E Moulder; E P Cohen; B L Fish; J M Taylor; P A Veno; L F Wolfe; W F Ward
Journal:  Exp Biol Med (Maywood)       Date:  2001-12

6.  Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases.

Authors:  Jean-Jacques Boffa; Ying Lu; Sandrine Placier; Adam Stefanski; Jean-Claude Dussaule; Christos Chatziantoniou
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

7.  Retinoic acid exacerbates experimental radiation nephropathy.

Authors:  John E Moulder; Brian L Fish; Kevin R Regner; Eric P Cohen; Thomas J Raife
Journal:  Radiat Res       Date:  2002-02       Impact factor: 2.841

8.  Identification of differentially expressed genes in mouse kidney after irradiation using microarray analysis.

Authors:  Jacqueline J C M Kruse; Johannes A M te Poele; Arno Velds; Ron M Kerkhoven; Liesbeth J Boersma; Nicola S Russell; Fiona A Stewart
Journal:  Radiat Res       Date:  2004-01       Impact factor: 2.841

9.  Late renal damage after total body irradiation and bone marrow transplantation in a mouse model: effect of radiation fractionation.

Authors:  A Safwat; O S Nielsen; S el-Badawy; J Overgaard
Journal:  Eur J Cancer       Date:  1995-06       Impact factor: 9.162

10.  Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.

Authors:  Oliver Gross; Bogdan Beirowski; Marie-Louise Koepke; Jeannine Kuck; Michael Reiner; Klaus Addicks; Neil Smyth; Eckhard Schulze-Lohoff; Manfred Weber
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

View more
  18 in total

1.  Injection of amniotic fluid stem cells delays progression of renal fibrosis.

Authors:  Sargis Sedrakyan; Stefano Da Sacco; Anna Milanesi; Liron Shiri; Astgik Petrosyan; Radka Varimezova; David Warburton; Kevin V Lemley; Roger E De Filippo; Laura Perin
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

Review 2.  Glomerular diseases: genetic causes and future therapeutics.

Authors:  Chih-Kang Chiang; Reiko Inagi
Journal:  Nat Rev Nephrol       Date:  2010-07-20       Impact factor: 28.314

3.  Cellular origins of type IV collagen networks in developing glomeruli.

Authors:  Dale R Abrahamson; Billy G Hudson; Larysa Stroganova; Dorin-Bogdan Borza; Patricia L St John
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

4.  Stem cell therapy for Alport syndrome: the hope beyond the hype.

Authors:  Oliver Gross; Dorin-Bogdan Borza; Hans-Joachim Anders; Christoph Licht; Manfred Weber; Stephan Segerer; Roser Torra; Marie-Claire Gubler; Laurence Heidet; Scott Harvey; Dominic Cosgrove; George Lees; Clifford Kashtan; Martin Gregory; Judy Savige; Jie Ding; Paul Thorner; Dale R Abrahamson; Corinne Antignac; Karl Tryggvason; Billy Hudson; Jeffrey H Miner
Journal:  Nephrol Dial Transplant       Date:  2008-12-25       Impact factor: 5.992

Review 5.  Alport syndrome--insights from basic and clinical research.

Authors:  Jenny Kruegel; Diana Rubel; Oliver Gross
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

Review 6.  Stem cells as a therapeutic approach to chronic kidney diseases.

Authors:  Sargis Sedrakyan; Susanne Angelow; Roger E De Filippo; Laura Perin
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

Review 7.  Glomerular pathology in Alport syndrome: a molecular perspective.

Authors:  Dominic Cosgrove
Journal:  Pediatr Nephrol       Date:  2011-04-01       Impact factor: 3.714

Review 8.  Searching for a treatment for Alport syndrome using mouse models.

Authors:  Kan Katayama; Shinsuke Nomura; Karl Tryggvason; Masaaki Ito
Journal:  World J Nephrol       Date:  2014-11-06

Review 9.  An update on the pathomechanisms and future therapies of Alport syndrome.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

10.  Stem cell therapies benefit Alport syndrome.

Authors:  Valerie LeBleu; Hikaru Sugimoto; Thomas M Mundel; Behzad Gerami-Naini; Elizabeth Finan; Caroline A Miller; Vincent H Gattone; Lingge Lu; Charles F Shield; Judah Folkman; Raghu Kalluri
Journal:  J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.